about
Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressantsInvestigation of -308G>A and -1031T>C polymorphisms in the TNFA promoter region in Polish peptic ulcer patients.Extract from Ribes nigrum leaves in vitro activates nitric oxide synthase (eNOS) and increases CD39 expression in human endothelial cells.Investigation of FJ 194940.1 gene alternative splicing in colon cancer and its association with clinicopathological parameters.The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report.BQ123 Stimulates Skeletal Muscle Antioxidant Defense via Nrf2 Activation in LPS-Treated Rats.Quantitative analysis of FJ 194940.1 gene expression in colon cancer and its association with clinicopathological parametersVirus-directed enzyme prodrug therapy and the assessment of the cytotoxic impact of some benzimidazole derivatives.SMAD-4 gene expression in human colorectal cancer: Comparison with some clinical and pathological parameters.Influence of block of NF-kappa B signaling pathway on oxidative stress in the liver homogenates.Synthesis, X-ray structures and cytotoxic activity of platinum(II), palladium(II) and copper(II) complexes with chelating ligands.Assessment of TNFA polymorphisms at positions -857 and -863 in Polish peptic ulcer patients.Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary research.CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies.Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.The identification and quantitative determination of rosmarinic acid and salvianolic acid B in hairy root cultures of Dracocephalum forrestii W.W. SmithAbscisic Acid Regulates the 3-Hydroxy-3-methylglutaryl CoA Reductase Gene Promoter and Ginsenoside Production in Hairy Root CulturesDoes the expression of the ACVR2A gene affect the development of colorectal cancer?No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cellsHuman leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia?Cyclin D1 protein and CCND1 gene expression in colorectal cancerDoes grape seed extract potentiate the inhibition of platelet reactivity in the presence of endothelial cells?NFKB2 gene expression in patients with peptic ulcer diseases and gastric cancerExpression level of CEBPA gene in acute lymphoblastic leukemia individualsBendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational statusThe impact of ABCB1 gene polymorphism and its expression on non-small-cell lung cancer development, progression and therapy - preliminary report
P50
Q26799957-336BD5B5-E23D-468B-98F6-76F4DB002220Q34432155-715E49EA-2131-4624-AE81-264E2B28B42DQ34623387-2EA9DCCC-8F7D-42AB-A7A7-1E9E2B0E1BCDQ36224431-B79BC99B-E2ED-44C0-8327-3586276707C9Q36323164-CB6F51B8-9ABC-4940-B082-A124304FD7C2Q36448483-2C543CEB-E836-4C4E-A875-B8CEF5083F30Q36936722-29104BE7-F3EA-4C61-B559-C281DBC55361Q38696221-44A4749B-4272-4C0E-B4DB-BBCA93763BCEQ39133474-61315FAA-7FB8-45AF-A60D-A252E43AE5CBQ39446755-25EF3934-DE36-4549-96BF-033E92E14147Q39725495-0A394892-56A3-4CDF-A1B7-99381129861DQ40831001-AFEC1C2C-F476-42BC-8BF7-14C7A71FF3C9Q41733654-16F9943A-D5F6-47C3-BA81-3923A4150912Q44153820-C86A079B-BD3C-4F0E-8097-2E9B619CC8A3Q44826211-623CF7BE-63D3-4A94-B6AE-3AA10D55410BQ46025647-D2BE0412-0526-45FD-8979-DE39799D92D4Q47743835-50810B18-5C9D-4200-8F69-B36B13C978BAQ51872796-8E9319BD-A292-496C-BF46-58577EB21DFAQ55355645-88366E64-0807-4CCC-A1A5-77F3134FB375Q60429693-B130A2D2-0457-44C8-B60B-9E8E41CE5712Q64087557-3C9AF591-996C-44C5-B0E5-3DB2BE9022DCQ64107586-4D0FFFB5-B26A-44A0-A599-493416EE071AQ79234857-A4DBF1C6-B114-45B4-9590-50E5B4870F4CQ80292713-2E21D227-017E-4247-BADB-7B13C962C0D6Q81917648-16F013D4-6F02-4181-A1C6-BAD0C98B7F73Q85816631-C2C38419-2E0D-479C-B237-44D7644E659CQ89706188-C7E7DC60-B23A-4A6D-9A39-4CEAC7E77C2EQ91012343-CF6EE60A-B892-49FB-961F-7575BADCB5E9Q91312385-EA7733A2-3E39-4862-A41C-1F158CEEFCE4Q91817232-FF951650-59A5-49C3-B3E8-06A57CB8D798
P50
description
Pools onderzoekster
@nl
hulumtuese
@sq
polska biolog molekularna
@pl
researcher
@en
հետազոտող
@hy
name
Ewa Balcerczak
@ast
Ewa Balcerczak
@ca
Ewa Balcerczak
@cs
Ewa Balcerczak
@en
Ewa Balcerczak
@es
Ewa Balcerczak
@gl
Ewa Balcerczak
@hr
Ewa Balcerczak
@hsb
Ewa Balcerczak
@it
Ewa Balcerczak
@nl
type
label
Ewa Balcerczak
@ast
Ewa Balcerczak
@ca
Ewa Balcerczak
@cs
Ewa Balcerczak
@en
Ewa Balcerczak
@es
Ewa Balcerczak
@gl
Ewa Balcerczak
@hr
Ewa Balcerczak
@hsb
Ewa Balcerczak
@it
Ewa Balcerczak
@nl
altLabel
Ewa Izabela Balcerczak
@pl
prefLabel
Ewa Balcerczak
@ast
Ewa Balcerczak
@ca
Ewa Balcerczak
@cs
Ewa Balcerczak
@en
Ewa Balcerczak
@es
Ewa Balcerczak
@gl
Ewa Balcerczak
@hr
Ewa Balcerczak
@hsb
Ewa Balcerczak
@it
Ewa Balcerczak
@nl
P214
P106
P1153
6603262359
P1412
P1559
Ewa Balcerczak
@pl
P21
P214
P27
P31
P3124
P496
0000-0001-5257-2914
P7859
viaf-102268958